Navigation
Navigation

Capricorn Health-tech Fund

The Capricorn Health-tech Fund (CHF) focuses on human health-technology investments. Health-technologies relate to the prevention, the diagnosis and the treatment of diseases.

iSTAR Medical receives US FDA approval to start pivotal trial for MINIject in glaucoma patients

News
- 15/07/2021
World-leading surgeons to join iSTAR Medical’s STAR-V study Wavre, Belgium: 15 July 2021 – iSTAR Medical, a med-tech company developing minimally-invasive implants for glaucoma surgery (MIGS), announced today that the U.S. Food and Drug Administration…
Read more

Nexstim extends agreement with Canadian distributor and receives order for three NBT® systems

News
- 25/05/2021
Helsinki, Finland: 25 May 2021 – Nexstim Plc (NXTMH:HEX, NXTMS:STO) announces that it has extended its agreement with Canadian Health Solutions group, the Company’s distributor in Canada, for an additional five years. The agreement continues…
Read more

Team
Dr Jos B. Peeters
Chairman Executive Committee - Venture Capital, IT
Dr Katya Smirnyagina
Executive Director Capricorn Health-tech Fund

Portfolio

Success stories

Ogeda

Ogeda [Belgium] is a drug development company with a chemistry service business focusing on discovery of small molecules targeting GPCRs.